Sponsor

The Affiliated Jiangning Hospital of Nanjing Medical University

Clinical research sponsor

Published trials4
Recruiting shown1
Roles1
SourceClinicalTrials.gov

Clinical trials

4 shown
Focused Power Ultrasound Mediated Inferior Perirenal Adipose Tissue Modification Therapy for Essential Hypertension (PARADISE HTN-III)NCT06283758 · collaborator · 2024-03-01
RECRUITING
AI-Based Ultrasound Prediction Model for Intracranial Pressure and Prognosis in Lung Cancer Patients With Leptomeningeal Metastasis: A Dual-Center StudyNCT07005791 · collaborator · 2025-07-01
NOT_YET_RECRUITING
Focused Power Ultrasound Mediated Inferior Perirenal Adipose Tissue Modification Therapy for Essential Hypertension (PARADISE-HTN-II)NCT06018493 · collaborator · 2023-09-01
COMPLETED
LIGHT-MCI Trial: GLP-1 Agonist, SGLT2 Inhibitor, and DPP-4 Inhibitor for MCI Remission in Type 2 DiabetesNCT05313529 · collaborator · 2022-10-08
COMPLETED

Sponsor roles

collaborator4

How to interpret this record

CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.